Zynerba Shares Plunge as Cannabis-Based Epilepsy Gel Fails Study https://www.doximity.com/doc_news/v2/entries/8719011 Zynerba Pharmaceuticals Inc’s stock lost more than half its value on Monday after the U.S. drug developer said its synthetic cannabis-based gel for epilepsy failed a mid-stage study. Zynerba’s gel contains a synthetically processed formulation of cannabidiol (CBD), a non-psychoactive component of the cannabis plant. […]
Filed under: General Problems | Leave a Comment »